findings home/archives       contact us       other AHC publications   

July 2006 Issue

Bradley Davis, MD, (left) and his colleagues at UC are specially trained to research, diagnose and treat diseases of the colon and rectum.
RSS feed

July's News Extras

By Jill Hafner
Published July 2006

Teaching Excellence Awards

The College of Medicine recently announced winners of its Gold and Silver Apple Awards, which honor excellence in teaching, and the Arnold P. Gold Foundation Humanism and Excellence in Teaching awards.

First-year medical students selected Bruce Giffin, PhD, for the Gold Apple, and Wan Lim, PhD,
and D.J. Lowrie, PhD, for Silver Apples. Second-year students awarded Paul Biddinger, MD, the Gold Apple, and Edmund Choi, PhD, and John Quinlan, MD, Silver Apples. The graduating class selected Richard Stevenson, MD, for the Gold Apple and LeAnn Coberly, MD, and Rick Ricer, MD, for Silver Apples.

Recipients of the Arnold P. Gold Foundation awards were residents Grady Alsabrook, MD, Brian Masterson, MD, Donna Mazloomdoost, MD, Jonathan Pfeifer, MD, Jeffrey Strawn, MD, and David Sunnenberg, MD.


First Rectal Microsurgery

UC colorectal surgeons have become the first in the Tristate to perform a transanal endoscopic microsurgical procedure (TEM), a minimally invasive method for removing rectal cancers without creating external incisions.

Bradley Davis, MD, assistant professor of surgery, says the procedure is a safe alternative to open surgery for removing very early rectal cancers and polyps, the precancerous masses that form on the lining of the colon or rectum.

The technique, known as “endoluminal surgery” uses a fiber-optic light source, a camera and specialized instruments to operate inside the rectum. Inserted through the anus, the instruments eliminate the need for an external incision and leave no visible scarring.


Lowe Endowment Created

The anesthesiology department recently established an endowed lectureship in honor of Edward Lowe, MD, a professor emeritus.

Lowe has been actively involved in student and resident education at UC for more than 35 years, focusing most of his career on pediatric anesthesiology and intensive care. He will present the first annual lectureship this fall.

Recognizing Humanism

Bruce Gebhardt, MD, of family medicine, and Matthew Meier, a fourth-year medical student, are the recipients of the 2006 Leonard Tow Humanism in Medicine Awards, presented by the Arnold P. Gold Foundation. The award, granted to one faculty member and one graduating medical student, recognizes the value of humanism in the delivery of care to patients and their families. The award winners are now official members of the Gold Humanism Honor Society.


Pharmacy Professor Earns National Rho Chi Honor

Michael Bottorff, PharmD, professor of pharmacy, has been selected by College of Pharmacy students to receive this year’s Rho Chi faculty excellence award.

The award is given to one faculty member at each of the 90 pharmacy colleges across the country. Bottorff, who teaches cardiovascular therapeutics, will receive the award at the American Association of Colleges of Pharmacy’s annual meeting July 8-12 in San Diego.

Heart Development Finding

Jay Hove, PhD, of genome science, has coauthored a paper in Science that describes a new mechanism for early vertebrate heart development—showing that the embryonic heart works differently than once thought.

Using improved in vivo imaging technology, Hove and a research team found that the valveless embryonic heart tube of zebrafish acts more like a suction pump rather than working similarly to the digestive tract, where food is moved by peristalsis (muscle contraction and relaxation).

says the finding could provide clues into heart diseases that result from improper development of the heart at birth and offers evidence of an embryonic origin for the suction action observed in the adult heart.

Bone Drug Prevents Cancer

Comparing the osteoporosis drug raloxifene (Evista) with the widely used breast cancer medication tamoxifen (Nolvadex), a nationwide research study found not only that the drugs were equally effective in preventing invasive breast cancer, but also that raloxifene had fewer side effects.

Led locally by UC surgeon Elizabeth Shaughnessy, MD, PhD, the STAR study (the Study of Tamoxifen and Raloxifene) was part of the National Surgical Adjuvant Breast and Bowel Project. It was funded by the National Cancer Institute.

 back to list | back to top